Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine

por Chan Kwong, Anna H.-X. P., Calvier, Elisa A. M., Fabre, David, Gattacceca, Florence, Khier, Sonia
Publicado 2020

Children Are Not Small Adults, but Can We Treat Them As Such?

por Krekels, Elke H.J., Calvier, Elisa A.M., van der Graaf, Piet H., Knibbe, Catherijne A.J.
Publicado 2019

Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

por Calvier, Elisa A. M., Krekels, Elke H. J., Välitalo, Pyry A. J., Rostami-Hodjegan, Amin, Tibboel, Dick, Danhof, Meindert, Knibbe, Catherijne A. J.
Publicado 2016

Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory

por Calvier, Elisa A. M., Nguyen, Thu Thuy, Johnson, Trevor N., Rostami-Hodjegan, Amin, Tibboel, Dick, Krekels, Elke H. J., Knibbe, Catherijne A. J.
Publicado 2018

The Influence of Normalization Weight in Population Pharmacokinetic Covariate Models

por Goulooze, Sebastiaan C., Völler, Swantje, Välitalo, Pyry A. J., Calvier, Elisa A. M., Aarons, Leon, Krekels, Elke H. J., Knibbe, Catherijne A. J.
Publicado 2018

A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children

por Brussee, Janneke M., Krekels, Elke H. J., Calvier, Elisa A. M., Palić, Semra, Rostami-Hodjegan, Amin, Danhof, Meindert, Barrett, Jeffrey S., de Wildt, Saskia N., Knibbe, Catherijne A. J.
Publicado 2019

Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments

por Calvier, Elisa A. M., Krekels, Elke H. J., Yu, Huixin, Välitalo, Pyry A. J., Johnson, Trevor N., Rostami‐Hodjegan, Amin, Tibboel, Dick, van der Graaf, Piet H., Danhof, Meindert, Knibbe, Catherijne A. J.
Publicado 2018